WASHINGTON DC., United States – November 2020: We are pleased to announce the Seventh International Conference on NPS to be held from 17 to 19 November 2020 in Washington DC. The conference is jointly organised by the International Society for the Study on Emerging Drugs (ISSED), the United Nations Office on Drugs and Crime (UNODC), the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), the World Anti-Doping Agency (WADA), University of Hertfordshire (UH) and the Center for Forensic Science Research and Education.

The main objectives of the seventh event are to share evidence-based information on NPS, including fentanyl and derivatives; improve understanding of clinical treatment and management of NPS use; explore policy and legislative responses to NPS; develop innovative prevention measures for vulnerable individuals; share analytical approaches to NPS detection and identification; explore motivations and socio-cultural factors underlying NPS use; networking and providing the opportunity meet leading experts in the field. The two-day scientific meeting program will be preceded on 17 November by a series of half day workshops covering clinical, treatment or toxicological topics, which will be an opportunity for networking and problem solving in an interactive environment.

The International Novel Psychoactive Substances (NPS) conference series, which started in Budapest in 2012, aims to share knowledge and strengthen collaboration on NPS among multidisciplinary professionals at the international level.

To attend this conference please register on the conference webpage. Abstract submission is open until Thuesday, 30 June 2020.

Source: VII International Conference on NPS

For more information, please see:

Conference webpage: www.novelpsychoactivesubstances.org/

Registration: www.novelpsychoactivesubstances.org/registration/

Abstract submission: www.novelpsychoactivesubstances.org/abstract-submission/